_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
HLTH
Primary Facts
Health Information Services
Name:
-
Sector:
17.47M
Industry:
3.29
CEO:
Total Employees:
Small Cap
Our Technological Advancement Rating
Our Rating:
-0.325771046
-1.158344711
Cue Health Inc (XNAS:HLTH) In-Depth Stock/Fundamental/Options Analysis Today
Primary Targets/Price Insights
Previous Close ($) :
Cue Health Inc (XNAS:HLTH)
One Month Price Target:
Six Month Price Target :
$3.31
Likely Price in One Year's Time:
Ticker:
$3.43
Likely Trading Range Today Under (Normal Volatility)
$3.33
Price Upper limit ($) :
$3.57
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
P40
This week:
$2.84
This month :
$2.28
Other Primary facts
Market Cap:
148.15M
Market Cap Classification:
496.31M
Number of Shares
IPO Date:
B
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
-18.52%
$1.27
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$4.48
28.88%
$2.10
$5.39
Medium risk (<10%) entry points
Buy Call
Sell Call
$3.99
Buy Put:
Sell Put:
$1.19
$2.59
$4.18
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
Health Information Services
Sharpe Ratio:
HLTH, is amongst the top 40% lowest yielding stocks in terms of daily returns
Comparison:
1.03%
-9.591117596
Sharpe ratio is -959.11% lower than the industry
Average Returns/Yield of
Health Information Services
Daily returns:
1
Weekly returns:
-0.56%
Monthly returns:
-2.78%
Yearly returns:
-133.51%
Comparison of returns:
-27.31183115
Classification:
Average annual returns/yield (last 3 years) is -2731.18% below industry average
Results of T-Test of Returns:
HLTH is a riskier investment compared to Nasdaq (IXIC)
Statistical test of Returns:
0.20
Volatility (measured by Standard Deviation)
Daily Volatility:
& is -487.13% lower than the market/S&P 500 average
Weekly Volatility:
6.40%
Monthly Volatility:
14.32%
Yearly Volatility:
28.64%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
124.84%
-
Value at Risk Analysis (VaR)
Daily VaR:
-
Weekly VaR:
-13.71%
Monthly VaR:
-30.65%
How Much Can the price of
Health Information Services
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
Risk of crash in next 6/12 months: Low (<25%)
Worst case (decline):
$1.29
This translates to price declining to:
-61%
This translates to price declining to:
>85%
Severe Crash Probability
-61.31%
What is Value at Risk (VaR)?
Risk Fundamentals
270.71%
HLTH is a 332.72% riskier investment compared to the market/S&P 500 & is 270.71% riskier than Nasdaq (IXIC)
HLTH is a 332.72% riskier investment compared to the market/S&P 500
Beta Examination of
Health Information Services
1.260
Expected beta in 1 year's time:
0.206
Expected beta in 3 year's time:
-
Unlevered (debt free) Beta:
Beta in relation to market/S&P 500--1.26
Beta in relation to Nasdaq (XNAS):
Returns are right (positive) skewed; mean returns are greater than median and mode returns
Beta in relation to all global stocks::
Beta is 44.83% above industry average
Beta Comparison & Analysis
Beta of competitors/peers::
1.199
0.178
Average Industry Beta:
Beta is 17.76% higher than peers
0.448275862
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
WACC is 47.31% above industry mean WACC
-35.41%
Alpha provided | Alpha Analysis
Alpha provided:
-
35.002
-92.484
Analysis of Cost of Capital of
Health Information Services
Equity cost of capital:
Alpha is -9248% below the market average
0.293
Unlevered (without debt) cost of capital:
Equity cost of capital is 29.33% above industry mean WACC
Before-tax cost of debt:
11.21%
After-tax cost of debt:
16.31%
Overall debt rating:
12.88%
Weighted average cost of capital (WACC):
16.31%
47.31%
Key Per-Share Metrics & Analysis
Revenue per share:
-
Revenue growth rate per share of (3Y):
Price to sales ratio is -91.92% below the industry mean
2071.21%
EPS:
-
Expected Annual growth rate of EPS (3Y):
-
-
Free cash flow (FCF) per share:
Price to book ratio is -86.24% below the industry mean
Growth rate in R&D investment/expenditure is -484.90% lower than the industry
-
Debt per share
Debt repayment rate in last quarter: 1.37%
EBITDA per share
Each employee generates -369% less EBITDA than industry average revenue per employee
Valuation Analysis Today of
Health Information Services
P/E Ratio:
Sustainable growth rate is -35.41% below industry average
P/E Ratio of Competitors/Peers:
8.28
-0.977342605
-
-
-
-
P/S (Price to Sales ratio):
$5.37
-0.919174992
P/B (Price to book value ratio):
Price to sales ratio is -91.92% below the industry mean
-
-
Net income growth rate (3Y):
Annual revenue growth rate is 2071.21% above the industry average
-125.40%
Dividend Analysis
Net income growth rate is -125.40% lower than the industry average net income growth rate
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dividend History:
-
--$0.00
--$0.00
--$0.00
--$0.00
--$0.00
-
In-depth Debt & Leverage Analysis
Debt to equity ratio:
-50.47%
Net debt to equity ratio:
The remaining useful life of property plant & equipment is: 6.7 years
Debt to assets ratio:
-37.20%
Net debt to assets ratio:
6.93%
-85.05%
Ability to repay debt:
Interest coverage ratio:
Debt-to-asset ratio is -85.05% below industry average
0.18
Looking forward:
Debt growth rate:
1.1x
310.11%
1.37%
Analysis of Key Statistics
Correlation of price movement with the market:
0.502678967
Statistical significance of correlation:
-2.43%
Average Correlation of the industry with the market:
0.033
-91.29%
R Squared (percentage of price movement explained by movement of the market):
0.033
Correlation of price movement with Nasdaq (^IXIC):
0.001
Covariance of price movement with the market:
0.005
Kurtosis
0.01
2.036
Skewness of returns:
Returns are more concentrated around the mean (platykurtic), compared to a normal distribution
0.540
Fundamental Analysis & Dupont Analysis of
Health Information Services
Gross Profit Margin Ratio:
432.32M
Operating Profit Margin Ratio:
Net profit margin is -162.79% lower than the industry
-173.97%
Net Profit Margin Ratio:
432.32M
Effective Tax Rate:
17.97%
0.355938635
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
Return on assets (ROA) is -622.42% lower than the industry
-477.41%
Financial Leverage
Asset Turnover Ratio (ROA):
Operating profit margin is -173.97% lower than the industry
-622.42%
Financial Leverage:
Interest coverage ratio is 17.80% more than industry average
Current Ratio:
Return on equity (ROE) is -477.41% lower than the industry
-0.350450392
Cash Conversion Cycle (days):
$0.34
0.490244515
Current ratio is -35.05% below industry average
Stock based compensation to net income ratio:
-
In-depth Efficiency Analysis
Revenue generated per employee:
Cash conversion cycle is 49.02% above industry average
0.203464029
EBITDA generated per employee:
Each employee generates 20% more revenue than industry average revenue per employee
-3.692397535
Profit generated per employee:
$1.18
-171%
Free cash flow (FCF) generated per employee:
Each employee generates -171% less net income/profit than industry average revenue per employee
-0.12784934
Assets/Capital per employee
Each employee generates -13% less free cash flow than industry average revenue per employee
-0.12784934
Research & Development (R&D) Analysis
50.39%
-4.849014872
Competitors/Peer firms of
Health Information Services
$4.97
RA MEDICAL SYSTEMS, INC. (XNYS:RMED)
RNN
APHB
IMMUNOCELLULAR THERAPEUTICS, LTD. (OTCM:IMUC)
DHR-PB
ASPEN TECHNOLOGY, INC. (XFRA:AST)
Constellation Software Inc. (XTSE:CSU)
ENZO BIOCHEM, INC. (XNYS:ENZ)
Current Analyst Ratings
-
Strong buy�4%
Buy�8%
Hold�0%
Sell�0%
Strong sell�0%
Income Statement
Period:
3/31/2022
Date:
Value
Revenue:
TTM
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
795.56M
363.24M
208%
71.62M
106.70M
169.60M
62.90M
274.59M
602.49M
514.00K
9.86M
43.12M
-97%
32.76M
16.88M
-137%
32.76M
Statement of Cash Flow
Date:
Period:
2.80M
Differed Income Tax :
10.61M
Stock Based Compensation :
-
Change in Working Capital :
16.04M
Accounts Receivables:
16.00K
Other Working Capital:
18.31M
Other Non-Cash Items:
- 1609.00K
Net Cash Provided by Operating Activities:
2.06M
Investments in PP&E:
31.52M
Net Acquisitions:
- 12782.00K
Purchases of Investments:
-
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
Value
3/31/2022
2022
Q1
426.47M
-
426.47M
75.83M
132.57M
66.55M
701.41M
266.96M
-
9.24M
-
-
6.16M
282.36M
-
983.77M
48.84M
10.21M
15.24M
84.63M
48.06M
191.74M
50.25M
6.36M
66.89M
-
258.63M
1.00K
- 21215.00K
-
Value
515.80M
-
725.14M
983.77M
-
60.47M
-
-
- 1273.00K
- 14055.00K
- 696.00K
-
-
-
- 177.00K
- 873.00K
-
16.59M
440.30M
423.71M
31.52M
- 14055.00K
Our Proprietary Portfolio Rating
Our Rating:
0.3321238
Price Forecast/Expected Price in Next 5 Years of
Health Information Services
2023
2024
2025
2026
2027
3.58785
$3.59
$3.89
$4.22
$4.58